Top

Published in:

01-03-2011

Clinicopathologic Characteristics of Colorectal Cancer Patients with Synchronous and Metachronous Gastric Cancer

Authors: Ernst Hanisch, Charalambos Batsis

Published in: World Journal of Surgery | Issue 3/2011

Excerpt

Colorectal cancer is the third most common cancer worldwide, with approximately 1 million new diagnoses each year. This high incidence is a major health problem in the USA and Europe. Synchronous and metachronous diagnosis of gastric cancer among patients with colorectal cancer is rare in the Western world, and at present no gastric cancer surveillance is recommended. However, gastric cancer is very common in Asian countries, and its surveillance in patients diagnosed with colorectal cancer might be of clinical benefit. …

Yoon SN, Oh ST, Lim SB et al (2010) Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer. World J Surg 34:2168–2176CrossRefPubMed

Markowitz SD, Bertagnolli MM (2009) Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 361:2449–2460CrossRefPubMed

Katsios C, Ziogas DE, Roukos DH (2010) Colorectal cancer: cetuximab, KRAS, BRAF, PIK3CA mutations and beyond. Expert Rev Gastroenterol Hepatol 4(5):525–529CrossRefPubMed

Roukos DH (2010) Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks. Pharmacogenomics J. doi:10.1038/tpj.2010.81 PubMed

Roukos DH (2010) Cancer Genome Explosion and Systems Biology: Impact on Surgical Oncology? Ann Surg Oncol. doi:10.1245/s10434-010-1355-y

Roukos DH (2010) Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice. Biomark Med 4(4):583–586CrossRefPubMed

Roukos DH, Ziogas DE, Katsios C (2010) Multigene assays and isolated tumor cells for early breast cancer treatment: time for bionetworks. Expert Rev Anticancer Ther 10(8):1187–1195CrossRefPubMed

Roukos DH (2010) Complete genome sequencing and network modeling to overcome trastuzumab resistance. Pharmacogenomics 11(8):1039–1043CrossRefPubMed

Roukos DH, Katsios C, Liakakos T (2010) Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn 10(5):541–545CrossRefPubMed

10.

Roukos DH (2010) Systems medicine: a real approach for future personalized oncology? Pharmacogenomics 11(3):283–287CrossRefPubMed

11.

Roukos DH, Ziogas D (2010) From tumor size and HER2 status to systems oncology for very early breast cancer treatment. Expert Rev Anticancer Ther 10(2):123–128CrossRefPubMed

12.

Roukos DH (2010) Next-generation sequencing and epigenome technologies: potential medical applications. Expert Rev Med Devices 7(6):723–726CrossRefPubMed

13.

Katsios C, Roukos DH (2010) Individual genomes and personalized medicine: life diversity and complexity. Per Med 7(4):347–350CrossRef

Title: Clinicopathologic Characteristics of Colorectal Cancer Patients with Synchronous and Metachronous Gastric Cancer
Authors: Ernst Hanisch
Charalambos Batsis
Publication date: 01-03-2011
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 3/2011
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-010-0868-7

At a glance: The STEP trials

Springer Medicine

Clinicopathologic Characteristics of Colorectal Cancer Patients with Synchronous and Metachronous Gastric Cancer

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2011

Reverse Airflow in Certain Chest Drains May be Misinterpreted as Prolonged Air Leakage

Is it Possible to Train Surgeons for Rural Africa? A Report of a Successful International Program

Mortality Associated with the Treatment of Gallstone Disease: A 10-Year Contemporary National Experience

Intraoperative Near-infrared Fluorescent Cholangiography (NIRFC) in Mouse Models of Bile Duct Injury: Reply

Anatomical Versus Nonanatomical Resection of Colorectal Liver Metastases: Is There a Difference in Surgical and Oncological Outcome?

Angiointervention: High Rates of Failure Following Blunt Renal Injuries